Cost-effectiveness Analysis with Influence Diagrams

被引:12
|
作者
Arias, M. [1 ]
Diez, F. J. [1 ]
机构
[1] UNED, Dept Artificial Intelligence, Madrid 28040, Spain
关键词
Cost-benefit analysis; cost-effectiveness analysis; decision trees; influence diagrams; INFERENCE; HEALTH;
D O I
10.3414/ME13-01-0121
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Background: Cost-effectiveness analysis (CEA) is used increasingly in medicine to determine whether the health benefit of an intervention is worth the economic cost. Decision trees, the standard decision modeling technique for non-temporal domains, can only perform CEA for very small problems. Objective: To develop a method for CEA in problems involving several dozen variables. Methods: We explain how to build influence diagrams (IDs) that explicitly represent cost and effectiveness. We propose an algorithm for evaluating cost-effectiveness IDs directly, i.e., without expanding an equivalent decision tree. Results: The evaluation of an ID returns a set of intervals for the willingness to pay separated by cost-effectiveness thresholds and, for each interval, the cost, the effectiveness, and the optimal intervention. The algorithm that evaluates the ID directly is in general much more efficient than the brute-force method, which is in turn more efficient than the expansion of an equivalent decision tree. Using OpenMarkov, an open-source software tool that implements this algorithm, we have been able to perform CEAs on several IDs whose equivalent decision trees contain millions of branches. Conclusion: IDs can perform CEA on large problems that cannot be analyzed with decision trees.
引用
收藏
页码:353 / 358
页数:6
相关论文
共 50 条
  • [1] Markov Influence Diagrams: A Graphical Tool for Cost-effectiveness Analysis
    Diez, Francisco J.
    Yebra, Mar
    Bermejo, Inigo
    Palacios-Alonso, Miguel A.
    Arias Calleja, Manuel
    Luque, Manuel
    Perez-Martin, Jorge
    MEDICAL DECISION MAKING, 2017, 37 (02) : 183 - 195
  • [2] Cost-effectiveness analysis with unordered decisions
    Diez, Francisco Javier
    Luque, Manuel
    Arias, Manuel
    Perez-Martin, Jorge
    ARTIFICIAL INTELLIGENCE IN MEDICINE, 2021, 117
  • [3] Economic foundations of cost-effectiveness analysis
    Garber, AM
    Phelps, CE
    JOURNAL OF HEALTH ECONOMICS, 1997, 16 (01) : 1 - 31
  • [4] Hemorrhoid Banding: A Cost-Effectiveness Analysis
    Coughlin, Ohmar P.
    Wright, Moriah E.
    Thorson, Alan G.
    Ternent, Charles A.
    DISEASES OF THE COLON & RECTUM, 2019, 62 (09) : 1085 - 1094
  • [5] THE RELATIONSHIP BETWEEN COST-EFFECTIVENESS ANALYSIS AND COST-BENEFIT-ANALYSIS
    JOHANNESSON, M
    SOCIAL SCIENCE & MEDICINE, 1995, 41 (04) : 483 - 489
  • [6] Costing and Perspective in Published Cost-Effectiveness Analysis
    Neumann, Peter J.
    MEDICAL CARE, 2009, 47 (07) : S28 - S32
  • [7] Discounting, Preferences, and Paternalism in Cost-Effectiveness Analysis
    Tinghog, Gustav
    HEALTH CARE ANALYSIS, 2012, 20 (03) : 297 - 318
  • [8] Growth and capacity for cost-effectiveness analysis in Africa
    Panzer, Ari D.
    Emerson, Joanna G.
    D'Cruz, Brittany
    Patel, Avnee
    Dabak, Saudamini
    Isaranuwatchai, Wanrudee
    Teerawattananon, Yot
    Ollendorf, Daniel A.
    Neumann, Peter J.
    Kim, David D.
    HEALTH ECONOMICS, 2020, 29 (08) : 945 - 954
  • [9] Cost-Effectiveness Analysis of Endoscopic Sleeve Gastroplasty
    Daniel, Michael
    Fritz, Cassandra
    Abebe, Tsehay
    Bazarbashi, Ahmad N.
    Sullivan, Shelby
    Chang, Su-Hsin
    Kushnir, Vladimir
    TECHNIQUES AND INNOVATIONS IN GASTROINTESTINAL ENDOSCOPY, 2024, 26 (03): : 244 - 251
  • [10] Cost-effectiveness analysis of paclitaxel
    Eandi, Mario
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2006, 7 (02) : 97 - 117